Company Filing History:
Years Active: 2006-2010
Title: Katsuya Kishikawa: Innovator in Pharmaceutical Research
Introduction
Katsuya Kishikawa is a notable inventor based in Mishima-gun, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that address various health issues. With a total of 3 patents to his name, Kishikawa's work is recognized for its potential impact on treating a range of diseases.
Latest Patents
Kishikawa's latest patents include innovative compounds that have therapeutic applications. One of his notable inventions is related to Piperidine derivatives, which are represented by a specific formula. These derivatives exhibit PDE4 inhibitory activity, making them useful for preventing and treating inflammatory diseases, diabetic diseases, allergic diseases, autoimmune diseases, osteoporosis, bone fractures, obesity, depression, Parkinson's disease, dementia, and ischemia-reperfusion injury. Another significant patent involves the use of sphingosine 1-phosphate as an active ingredient for treating pulmonary fibrosis. This anti-fibrotic agent, which includes a sphingosine 1-phosphate receptor agonist, is effective in preventing and treating diseases caused by fibrosis in various organs, such as pulmonary fibrosis and chronic renal failure.
Career Highlights
Katsuya Kishikawa is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to advance his research in pharmaceuticals. His work is characterized by a commitment to developing effective treatments for complex health conditions.
Collaborations
Kishikawa has collaborated with esteemed colleagues, including Hisao Nakai and Shigeru Matsumoto. These partnerships have contributed to the success of his research endeavors and the development of innovative pharmaceutical solutions.
Conclusion
Katsuya Kishikawa stands out as a dedicated inventor in the pharmaceutical industry, with a focus on creating compounds that address critical health challenges. His contributions through patents and collaborations highlight his commitment to improving patient outcomes.